MENU

HOLX Stock Hologic (HOLX, $54.48) was a top loser this quarter, falling -15.52%

A.I.dvisor
at Tickeron.com
Loading...
HOLX - Hologic
Tickeron

Loading...

Price: $54.48
Daily change: -$0.34 (-0.62%)
Daily volume: 1.8M
3-month price change: -$10.01 (-15.52%)
Capitalization: $12.1B
Industry: Medical Specialties
Hologic (HOLX, $54.48) was a top loser over the last three months, falling -1 to $54.48 per share. A.I.dvisor analyzed 392 stocks in the Medical Specialties Industry for the 3-month period ending May 22, 2025, and found that of them (2) exhibited an Uptrend while of them (7) demonstrated a Downtrend.

Momentum Indicator for HOLX turns negative, indicating new downward trend

HOLX saw its Momentum Indicator move below the 0 level on August 25, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned negative. In of the 98 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HOLX turned negative on August 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOLX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 56 cases where HOLX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 50-day moving average for HOLX moved above the 200-day moving average on August 29, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOLX advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 219 cases where HOLX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HOLX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.067) is normal, around the industry mean (11.022). P/E Ratio (27.701) is within average values for comparable stocks, (59.569). Projected Growth (PEG Ratio) (1.471) is also within normal values, averaging (1.744). HOLX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (3.804) is also within normal values, averaging (12.728).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOLX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

View a ticker or compare two or three
HOLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HOLX showed earnings on July 30, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of diagnostics products, medical imaging systems and surgical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
250 Campus Drive
Phone
+1 508 263-2900
Employees
6990
Web
http://www.hologic.com